This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations, and practice treatment implications.
This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations and practice treatment implications.
It offers something new to the field of dementia assessment and treatment by shining a light on the multiple comorbidities that compound the patient’s clinical presentation and exacerbate cognitive decline and by presenting differential diagnoses and the imperative to rule out reversible causes of cognitive impairment/dementia in one key text. Taking a global approach, chapters include mild cognitive impairment and the impact of drugs and substance abuse and other medication effects. The book goes on to look at depression and other psychiatric presentations, chronic pain, metabolic conditions, and tumors and other space-occupying lesions. Infectious diseases and other medical illnesses that affect cognition are explored, along with the impact of sleep disorders and delirium. The book concludes with a focus on applications and treatment when maximizing an older person’s functioning and assessing their cognition and/or their capacity.
It is essential reading for clinicians, researchers, and specialist nurses in aging and dementia as well as students of neuropsychology/neurocognition, medicine, and health and social work.
1. Introduction: Reversible Conditions and Modifiable Risk Factors for
Dementia Lynn A. Schaefer and Thomas J. Farrer.
2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment Sarah E. Cote and Lisa
D. Ravdin.
3. Drugs and Substance Abuse Jakob Thorn, Doug Johnson-Greene, and
Cady Block.
4. Medication Effects: The Cognitive Impact of Drug Classes,
Polypharmacy, and Drug Interactions. Eric Silk and Dawson Hedges
5.
Depression and Other Psychiatric Presentations Shawn McClintock and Allison
Gregg.
6. Persistent Pain Yana Suchy, Michelle Gereau Mora, and Libby A.
DesRuisseaux.
7. Metabolic Disorders and Reversible Causes of Cognitive
Dysfunction Margaret E. Wiggins, and Marc A. Norman.
8. Brain Tumors Jennifer
L. Nosker and Michael W. Parsons.
9. Infectious Diseases and Dementia:
Potential Interventions for Prevention and Treatment Morgan Chase McClellan,
Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W. Hedges, and Thomas J.
Farrer.
10. Normal Pressure Hydrocephalus Drew M. Hodis, Jennifer S. Shalam,
Wei-Qian Wang, and Susan Farella-Busch.
11. Other Medical Illnesses and
Cognitive Impairment Eric M. Watson, Amelia J. Hicks, and Jacqueline H.
Becker.
12. The mpact of Sleep and Sleep Disorders on Cognitive Health:
Reversibility of Cognitive Impairment Associated with Sleep Disorders Mariya
Narizhnaya and Matthew R. Ebben.
13. Concepts of Multimorbidity in Clinical
Neuropsychology Jason W. Krellman and Robert Leavenworth.
14. Delirium Kirk
J. Stucky and Tracy Shannon.
15. Conclusion and Applications Thomas J. Farrer
and FLynn A. Schaefer.
Thomas J. Farrer is a board-certified clinical neuropsychologist and Assistant Professor at the University of Idaho where he serves as Associate Program Director in the School of Health and Medical Professions. He has published additional books and articles in neuropsychology and has research interests in dementia and neuroepidemiology.
Lynn A. Schaefer is a board-certified clinical neuropsychologist and Director of Neuropsychology at Nassau University Medical Center. She is a fellow of the APA and National Academy of Neuropsychology. She has published additional books and articles in neuropsychology and has interests in dementia, brain injury, educational outreach, and decision-making capacity.
Rohkem infot Taylor & Francis e-raamatute kohta